Evidence map›Paper›PMID 41846477›Full record

ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2025

The Diagnostic Potential and Regulatory Mechanisms of miR-3180-3p in Metabolic Dysfunction-Associated Fatty Liver Disease with Respect to Inflammation and Oxidative Stress.

Kexiu Song, Peng Qi

Abstract read
In one paragraph

Article in The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kexiu SongDepartment of Endocrinology, Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
Peng QiDepartment of Gastroenterology, Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsmiR-3180-3p has been linked to hepatocellular carcinoma progression, but its role and molecular mechanisms in metabolic dysfunction-associated steatotic liver disease (MASLD) are still unclear. The objective is to explore whether miR-3180-3p serves as a diagnostic biomarker for MASLD and elucidate its function in mediating hepatic inflammatory and oxidative stress responses. MATERIALS AND

methodsThis cross-sectional study included 117 patients with MASLD and 100 healthy controls. Serum and cellular RNA were extracted for real-time polymerase chain reaction analysis. In vitro experiments utilized HepG2 cells treated with free fatty acids (FFAs) to mimic MASLD-related stress conditions, evaluating miR-3180-3p expression levels and its effects on oxidative stress mark ers (malondialdehyde, superoxide dismutase) and inflammatory cytokines (tumor necrosis factor-α, interleukin-6 (IL-6), IL-1β). Target genes of miR-3180-3p were identified using bioinformatics and dual-luciferase assays.

resultsSerum miR-3180-3p levels were significantly higher in MASLD patients than controls, showing strong diagnostic value and potential as a biomarker. Multivariate analysis identified it, along with C-reactive protein (CRP) and high-density lipoprotein (HDL) cholesterol, as an independent risk factor for MASLD. Its expression positively correlated with triglycerides, low-density lipoprotein cholesterol, white blood cell count, CRP, Fibrosis-4, and oxidative stress markers (OA, PA), but negatively with HDL cholesterol. In FFA-treated cells, higher miR-3180-3p was linked to increased oxidative stress and inflammation. SKI, a direct target of miR-3180-3p, when silenced, reversed the protective effects of miR-3180-3p inhibition against FFA-induced cellular damage.

conclusionmiR-3180-3p is a promising diagnostic biomarker for MASLD and contributes to disease progression by enhancing hepatic inflammation and oxidative stress via targeting SKI.   Cite this article as: Song K, Qi P. The diagnostic potential and regulatory mechanisms of miR-3180-3p in metabolic dysfunction- associated fatty liver disease with respect to inflammation and oxidative stress. Turk J Gastroenterol. 2026;37(3):310-321.

Indexed as

Fatty LiverInflammationMicroRNAsOxidative StressAdultBiomarkersCase-Control StudiesCross-Sectional StudiesCytokinesFemaleHep G2 CellsHumansMaleMiddle AgedNon-alcoholic Fatty Liver DiseaseBiomarkersCytokinesMicroRNAs

Identifiers

PMID41846477
PMCPMC12994421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.